{"id":"cannabinoids","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT04201197","NCT06471647","NCT07091747","NCT07043452","NCT05049733","NCT05880563","NCT02783092","NCT06815744","NCT02815540","NCT04582591","NCT02921282","NCT07218471","NCT03518801","NCT02604992","NCT03078309","NCT00697034","NCT05632627","NCT02523183","NCT00444769","NCT00959218","NCT03157778","NCT02683018","NCT02177513","NCT03984565","NCT04965740","NCT02902081","NCT06930703","NCT02710331","NCT06772753","NCT00438139","NCT02952196","NCT03805750","NCT07224932","NCT05803434","NCT06595576","NCT00678730","NCT07401628","NCT02286986","NCT03877991","NCT02811510","NCT06099379","NCT06003062","NCT05516823","NCT03604341","NCT06159686","NCT06072573","NCT01719497","NCT04512365","NCT04193631","NCT06473701"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Cannabinoids","companyId":"new-york-state-psychiatric-institute","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"New York State Psychiatric Institute","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Cannabinoids","indications":{"approved":[{"name":"Muscle Spasticity due to Multiple Sclerosis","diseaseId":"muscle-spasticity-due-to-multiple-sclerosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04201197","phase":"Phase 1","title":"Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs","status":"COMPLETED","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":22,"indication":"Drug-Interactions","completionDate":"2022-07-28"},{"nctId":"NCT06471647","phase":"EARLY/Phase 1","title":"Effects of Drugs on Stress Memories","status":"COMPLETED","sponsor":"University of Chicago","isPivotal":false,"enrollment":36,"indication":"Delta-9-tetrahydrocannabinol (THC), Stress","completionDate":"2025-03-25"},{"nctId":"NCT07091747","phase":"Phase 1","title":"Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","isPivotal":false,"enrollment":61,"indication":"Alzheimer Disease (AD)","completionDate":"2025-12-12"},{"nctId":"NCT07043452","phase":"EARLY/Phase 1","title":"Measuring Acute Drug Demand in Humans II","status":"WITHDRAWN","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":0,"indication":"Healthy Volunteers","completionDate":"2027-12-30"},{"nctId":"NCT05049733","phase":"Phase 1","title":"The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A","status":"COMPLETED","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":21,"indication":"Cannabis","completionDate":"2023-06-01"},{"nctId":"NCT05880563","phase":"Phase 1","title":"A Monocentric, Controlled, Open Label, Phase I, First-in-human Trial to Investigate the Regional Distribution of [18F]RoSMA-18-d6 in the Brain and Spinal Cord to Assess Cannabinoid Type 2 Receptor (CB","status":"NOT_YET_RECRUITING","sponsor":"Markus Weber","isPivotal":false,"enrollment":30,"indication":"Amyotrophic Lateral Sclerosis","completionDate":"2026-09"},{"nctId":"NCT02783092","phase":"Phase 3","title":"A Double-blind, Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epileptic Crisis in Children and Adolescents","status":"UNKNOWN","sponsor":"Antonio Waldo Zuardi","isPivotal":true,"enrollment":126,"indication":"Epilepsy","completionDate":"2024-09-25"},{"nctId":"NCT06815744","phase":"N/A","title":"Correlation Between BDNF/CB1R Expression and Postoperative Pain and Recovery in Patients With Preoperative Sleep Disorders","status":"COMPLETED","sponsor":"Gansu Provincial Hospital","isPivotal":false,"enrollment":200,"indication":"Total Knee Arthroplasty (TKA)","completionDate":"2024-01-31"},{"nctId":"NCT02815540","phase":"Phase 1","title":"The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children","status":"TERMINATED","sponsor":"Gillette Children's Specialty Healthcare","isPivotal":false,"enrollment":2,"indication":"Lennox-Gastaut Syndrome, Dravet Syndrome","completionDate":"2018-12-01"},{"nctId":"NCT04582591","phase":"Phase 2","title":"A Phase II Trial of Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy in Patients Receiving Oxaliplatin or Paclitaxel Based Chemotherapy","status":"UNKNOWN","sponsor":"Zealand University Hospital","isPivotal":false,"enrollment":54,"indication":"Chemotherapy-induced Peripheral Neuropathy","completionDate":"2023-08-30"},{"nctId":"NCT02921282","phase":"N/A","title":"Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","isPivotal":false,"enrollment":26,"indication":"Cigarette Smoking Behavior","completionDate":"2019-11-29"},{"nctId":"NCT07218471","phase":"NA","title":"Prospective Changes in Patient-reported and Objective Functioning Following Reduction of Cannabis Use","status":"RECRUITING","sponsor":"Medical University of South Carolina","isPivotal":false,"enrollment":176,"indication":"Cannabis Use Disorder","completionDate":"2030-01-30"},{"nctId":"NCT03518801","phase":"Phase 2","title":"Cannabidiol as an Adjunctive to Prolonged Exposure for the Treatment of PTSD","status":"COMPLETED","sponsor":"VA Office of Research and Development","isPivotal":false,"enrollment":136,"indication":"PTSD","completionDate":"2025-09-30"},{"nctId":"NCT02604992","phase":"NA","title":"An Open-Label, Randomized, Single-Dose, Two-Period, Two-Way Crossover Comparative Bioavailability Study of Dronabinol Oral Solution, 4.25 mg to Marinol Capsule, 5 mg in Healthy Volunteers Under Fed Co","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","isPivotal":false,"enrollment":54,"indication":"Healthy","completionDate":"2015-12"},{"nctId":"NCT03078309","phase":"EARLY/Phase 1","title":"A Controlled Study of the Effect of Cannabis on Visual Functions in Healthy Subjects and in Retinitis Pigmentosa Patients","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","isPivotal":false,"enrollment":50,"indication":"Retinitis Pigmentosa, Retinal Degeneration","completionDate":"2021-12"},{"nctId":"NCT00697034","phase":"Phase 4","title":"Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin","status":"TERMINATED","sponsor":"Wake Forest University","isPivotal":false,"enrollment":12,"indication":"Psoriasis","completionDate":"2008-12"},{"nctId":"NCT05632627","phase":"Phase 2","title":"Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial","status":"COMPLETED","sponsor":"University of Colorado, Denver","isPivotal":false,"enrollment":43,"indication":"Brain Injuries, Traumatic","completionDate":"2025-07-07"},{"nctId":"NCT02523183","phase":"N/A","title":"The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy","status":"UNKNOWN","sponsor":"University of Colorado, Denver","isPivotal":false,"enrollment":150,"indication":"Epilepsy, Unspecified, Refractory (Medically)","completionDate":"2020-11"},{"nctId":"NCT00444769","phase":"Phase 2","title":"A Multi-Centre, Randomised, Single-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy of Single Pre-Emptive Doses of GW842166X, a Non-Cannabinoid CB2 Receptor Agonist, on Pain","status":"COMPLETED","sponsor":"GlaxoSmithKline","isPivotal":false,"enrollment":112,"indication":"Pain","completionDate":""},{"nctId":"NCT00959218","phase":"Phase 3","title":"Multi-centre, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Patients With Multiple Sclerosis Associated With C","status":"COMPLETED","sponsor":"Bionorica Research GmbH","isPivotal":true,"enrollment":240,"indication":"Central Neuropathic Pain in Multiple Sclerosis","completionDate":"2010-04"},{"nctId":"NCT03157778","phase":"NA","title":"Relation Between Pregnenolone Endocannabinoids in Normal-weight and Obese Men","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","isPivotal":false,"enrollment":25,"indication":"Obesity","completionDate":"2017-11-02"},{"nctId":"NCT02683018","phase":"Phase 1","title":"Investigation of Cannabis for Chronic Pain and Palliative Care","status":"WITHDRAWN","sponsor":"New York State Psychiatric Institute","isPivotal":false,"enrollment":0,"indication":"Chronic Pain","completionDate":"2021-10-28"},{"nctId":"NCT02177513","phase":"Phase 1","title":"Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","isPivotal":false,"enrollment":28,"indication":"Cannabis Use","completionDate":"2016-04-27"},{"nctId":"NCT03984565","phase":"Phase 2","title":"PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product","status":"RECRUITING","sponsor":"Staci Gruber, Ph.D.","isPivotal":false,"enrollment":25,"indication":"Chronic Pain","completionDate":"2026-09"},{"nctId":"NCT04965740","phase":"N/A","title":"EMPOWER Study: Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids: Observational Study With First Responders and Military Personnel Examining Previous Use Experi","status":"COMPLETED","sponsor":"Empower Research Inc","isPivotal":false,"enrollment":102,"indication":"PTSD, Anxiety","completionDate":"2022-02-15"},{"nctId":"NCT02902081","phase":"NA","title":"Effects of Cannabidiol on Responses to Emotional Stimuli","status":"COMPLETED","sponsor":"University of Chicago","isPivotal":false,"enrollment":38,"indication":"Drug Addiction","completionDate":"2017-03"},{"nctId":"NCT06930703","phase":"Phase 1","title":"Treatment of Sickle Cell Pain and Inflammation With Cannabidiol (SPICe)","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","isPivotal":false,"enrollment":52,"indication":"Sickle Cell Disease","completionDate":"2027-02-01"},{"nctId":"NCT02710331","phase":"Phase 1","title":"Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","isPivotal":false,"enrollment":40,"indication":"Cannabis, Alcohol Effect","completionDate":"2025-12"},{"nctId":"NCT06772753","phase":"Phase 1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":50,"indication":"Psychedelic Effects in Healthy Volunteers","completionDate":"2027-12"},{"nctId":"NCT00438139","phase":"Phase 1","title":"Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers","status":"TERMINATED","sponsor":"National Institute on Drug Abuse (NIDA)","isPivotal":false,"enrollment":6,"indication":"Marijuana Dependence","completionDate":"2007-03"},{"nctId":"NCT02952196","phase":"Phase 2","title":"Cannabinoids as a New Intervention for Amphetamine Dependence: A Proof-of-concept Study","status":"WITHDRAWN","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","isPivotal":false,"enrollment":0,"indication":"Amphetamine Addiction","completionDate":"2017-12"},{"nctId":"NCT03805750","phase":"Phase 1","title":"A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET).","status":"COMPLETED","sponsor":"University of California, San Diego","isPivotal":false,"enrollment":7,"indication":"Essential Tremor","completionDate":"2020-11-30"},{"nctId":"NCT07224932","phase":"Phase 2","title":"A Randomized, Double-blind, Placebo-controlled Parallel Study of the Tolerability and Efficacy of High Cannabidiol (CBD) Cannabis Extract for the Treatment of Patients With Idiopathic Restless Legs Sy","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","isPivotal":false,"enrollment":60,"indication":"Restless Leg Syndrome","completionDate":"2026-02-25"},{"nctId":"NCT05803434","phase":"Phase 2","title":"Open-label Pilot Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution as an Adjunctive Treatment for Children and Young Adults With Rare Disease-associated Severe Epilepsy","status":"UNKNOWN","sponsor":"Meyer Children's Hospital IRCCS","isPivotal":false,"enrollment":30,"indication":"Epilepsy, Rare Diseases","completionDate":"2025-03-01"},{"nctId":"NCT06595576","phase":"NA","title":"Dose-dependent Effects of Cannabis Edibles on Simulated Driving Performance","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","isPivotal":false,"enrollment":52,"indication":"Cannabis, Driving Under the Influence","completionDate":"2025-04-04"},{"nctId":"NCT00678730","phase":"EARLY/Phase 1","title":"Pharmacogenetics of Cannabinoid Response","status":"COMPLETED","sponsor":"Yale University","isPivotal":false,"enrollment":72,"indication":"COMT Gene Polymorphism","completionDate":"2014-09-11"},{"nctId":"NCT07401628","phase":"NA","title":"Randomised, Controlled, Interventional Single-center Study for the Design and Evaluation of an In-vehicle Real-time System for Detecting Cannabis-impaired Driving (CID)","status":"RECRUITING","sponsor":"University of Bern","isPivotal":false,"enrollment":45,"indication":"Driving Under the Influence, Cannabis-impaired Driving","completionDate":"2026-06-19"},{"nctId":"NCT02286986","phase":"Phase 1","title":"A 2-part Study to Investigate the Dose-ranging Pharmacokinetics and Tolerability, Followed by the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With","status":"COMPLETED","sponsor":"University of Utah","isPivotal":false,"enrollment":26,"indication":"Epilepsy","completionDate":"2019-06-13"},{"nctId":"NCT03877991","phase":"EARLY/Phase 1","title":"Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","isPivotal":false,"enrollment":12,"indication":"Pain","completionDate":"2025-02-19"},{"nctId":"NCT02811510","phase":"Phase 1","title":"Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I","status":"RECRUITING","sponsor":"Yale University","isPivotal":false,"enrollment":40,"indication":"Cannabis","completionDate":"2026-12"},{"nctId":"NCT06099379","phase":"Phase 1","title":"Modulation of ∆9-tetrahydrocannabinol Acute Psychoactive Effects by Ranging Doses of Cannabidiol in Healthy, Occasional Cannabis Users: a Controlled, Triple Blind, Randomized, Cross-over Study","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","isPivotal":false,"enrollment":100,"indication":"Cannabis, THC","completionDate":"2026-12-31"},{"nctId":"NCT06003062","phase":"N/A","title":"Suppression of Upper Lip Hair Growth Using Novel Hemp Extract - A Case Series","status":"UNKNOWN","sponsor":"Medical Life Care Planners, LLC","isPivotal":false,"enrollment":25,"indication":"Hirsutism, Hair Diseases","completionDate":"2023-12-01"},{"nctId":"NCT05516823","phase":"N/A","title":"Personality and Drug Use","status":"UNKNOWN","sponsor":"Psychedelic Data Society","isPivotal":false,"enrollment":1000,"indication":"No Conditions Study Focus on Substance Use and Personality","completionDate":"2023-11"},{"nctId":"NCT03604341","phase":"Phase 4","title":"Cannabinoid Analgesia for Medical Abortion: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Oregon Health and Science University","isPivotal":false,"enrollment":72,"indication":"Medical Abortion, Pain","completionDate":"2019-05-28"},{"nctId":"NCT06159686","phase":"Phase 1","title":"This Study Aims to Compare the Efficacy of Hemp-containing Cream and a Placebo in the Treatment of Uremic Pruritus in Hemodialysis Patients. Patients Were Randomly Assigned Either the Hemp-containing ","status":"COMPLETED","sponsor":"Thammasat University Hospital","isPivotal":false,"enrollment":60,"indication":"Uremic Pruritus","completionDate":"2023-12-08"},{"nctId":"NCT06072573","phase":"Phase 3","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","isPivotal":true,"enrollment":558,"indication":"Pain, Pain Syndrome","completionDate":"2024-12-31"},{"nctId":"NCT01719497","phase":"N/A","title":"Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET","status":"COMPLETED","sponsor":"Yale University","isPivotal":false,"enrollment":74,"indication":"Obesity, Alcohol Dependence","completionDate":"2014-05"},{"nctId":"NCT04512365","phase":"EARLY/Phase 1","title":"Brain-Behavior Markers of Reward and Drug Effects in Young Adults","status":"COMPLETED","sponsor":"University of Illinois at Chicago","isPivotal":false,"enrollment":141,"indication":"Cannabis Use, Healthy","completionDate":"2025-05-02"},{"nctId":"NCT04193631","phase":"Phase 1","title":"A Controlled-Dose Study Using A One Time Low Dose Cannabidiol Tablet For The Treatment of Mild to Moderate Musculoskeletal Pain","status":"COMPLETED","sponsor":"Pure Green","isPivotal":false,"enrollment":16,"indication":"Musculoskeletal Pain","completionDate":"2019-12-09"},{"nctId":"NCT06473701","phase":"Phase 3","title":"BONG: Reducing Severe Breathlessness With Dronabinol in the Severe and Very Severe Chronic Obstructive Pulmonary Disease Patient Group - A Randomized, Double-Blind, Placebo-Controlled, Crossover Study","status":"RECRUITING","sponsor":"Vejle Hospital","isPivotal":true,"enrollment":30,"indication":"COPD, Breathlessness","completionDate":"2026-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}